Joseph Kovalchin

772 total citations
20 papers, 605 citations indexed

About

Joseph Kovalchin is a scholar working on Immunology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Joseph Kovalchin has authored 20 papers receiving a total of 605 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 7 papers in Molecular Biology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Joseph Kovalchin's work include Heat shock proteins research (5 papers), Ocular Surface and Contact Lens (5 papers) and Immunotherapy and Immune Responses (4 papers). Joseph Kovalchin is often cited by papers focused on Heat shock proteins research (5 papers), Ocular Surface and Contact Lens (5 papers) and Immunotherapy and Immune Responses (4 papers). Joseph Kovalchin collaborates with scholars based in United States, France and United Kingdom. Joseph Kovalchin's co-authors include Rajiv Y. Chandawarkar, Ruibo Wang, Charles G. Drake, Adam C. Adler, Marianne A. Mihalyo, Adam T. Hagymasi, Melinda Sanders, Eric S. Furfine, Bracken M. King and Sharon A. Townson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Blood.

In The Last Decade

Joseph Kovalchin

18 papers receiving 592 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph Kovalchin United States 11 337 208 97 95 61 20 605
Norikatsu Mizumoto United States 11 278 0.8× 508 2.4× 118 1.2× 29 0.3× 63 1.0× 15 1.0k
Sophie Bosset France 9 253 0.8× 285 1.4× 75 0.8× 29 0.3× 117 1.9× 12 793
Shoso Yamamoto Japan 19 268 0.8× 274 1.3× 36 0.4× 57 0.6× 56 0.9× 72 1.0k
Meera S. Ramakrishnan United States 14 386 1.1× 94 0.5× 250 2.6× 94 1.0× 90 1.5× 30 825
K Heije Netherlands 7 159 0.5× 305 1.5× 36 0.4× 111 1.2× 46 0.8× 8 648
Tiffany Frey United States 6 401 1.2× 139 0.7× 93 1.0× 68 0.7× 41 0.7× 7 655
Hongmei Fu China 16 216 0.6× 403 1.9× 26 0.3× 50 0.5× 109 1.8× 45 848
S. S. Rabinowitz United Kingdom 7 265 0.8× 321 1.5× 132 1.4× 39 0.4× 89 1.5× 8 786
Mara Hincenbergs United States 12 293 0.9× 132 0.6× 205 2.1× 42 0.4× 64 1.0× 12 775
K Albrandt United States 14 468 1.4× 368 1.8× 74 0.8× 219 2.3× 82 1.3× 16 961

Countries citing papers authored by Joseph Kovalchin

Since Specialization
Citations

This map shows the geographic impact of Joseph Kovalchin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Kovalchin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Kovalchin more than expected).

Fields of papers citing papers by Joseph Kovalchin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Kovalchin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Kovalchin. The network helps show where Joseph Kovalchin may publish in the future.

Co-authorship network of co-authors of Joseph Kovalchin

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Kovalchin. A scholar is included among the top collaborators of Joseph Kovalchin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Kovalchin. Joseph Kovalchin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pinkstaff, Jason, Emma McCullagh, Anita Grover, et al.. (2023). Safety, pharmacokinetics and CNS distribution of tralesinidase alfa administered via intracerebroventricular infusion to juvenile cynomolgus monkeys. Toxicology Reports. 10. 357–366.
2.
Muschol, Nicole, İlyas Okur, Fatih Süheyl Ezgü, et al.. (2022). A phase I/II study on intracerebroventricular tralesinidase alfa in patients with Sanfilippo syndrome type B. Journal of Clinical Investigation. 133(2). 9 indexed citations
3.
Muschol, Nicole, İlyas Okur, Fatih Süheyl Ezgü, et al.. (2021). Tralesinidase alfa (AX 250) enzyme replacement therapy for Sanfilippo syndrome type B. Molecular Genetics and Metabolism. 132(2). S75–S75.
4.
Rubio‐Beltrán, Eloísa, Alejandro Labastida‐Ramírez, Kristian Agmund Haanes, et al.. (2019). Characterization of binding, functional activity, and contractile responses of the selective 5‐HT1F receptor agonist lasmiditan. British Journal of Pharmacology. 176(24). 4681–4695. 49 indexed citations
5.
Kovalchin, Joseph, Bracken M. King, Elizabeth Hopkins, et al.. (2017). Preclinical Development of EBI-005: An IL-1 Receptor-1 Inhibitor for the Topical Ocular Treatment of Ocular Surface Inflammatory Diseases. Eye & Contact Lens Science & Clinical Practice. 44(3). 170–181. 15 indexed citations
6.
Tubridy, Karen L., et al.. (2015). Clinical Development of EBI-005, a Novel Interleukin-1 Receptor Inhibitor, for Patients with Ocular Surface Inflammation. Investigative Ophthalmology & Visual Science. 56(7). 4488–4488. 1 indexed citations
7.
Goldstein, Michael H., Karen L. Tubridy, Eric S. Furfine, et al.. (2015). A Phase 2 Exploratory Study of a Novel Interleukin-1 Receptor Inhibitor (EBI-005) in the Treatment of Moderate-to-Severe Allergic Conjunctivitis. Eye & Contact Lens Science & Clinical Practice. 41(3). 145–155. 18 indexed citations
8.
Schmidt, Michael, et al.. (2014). Optimized IL-6 Blockade for the Treatment of Diabetic Macular Edema. Investigative Ophthalmology & Visual Science. 55(13). 1062–1062. 6 indexed citations
9.
Furfine, Eric S., et al.. (2013). Preclinical Development of EBI-005: a Potent Interleukin-1 (IL-1) Receptor-1 (R1) Blocker for Topical Ocular Administration was Safe in GLP Toxicology Studies and Active in a Mouse Model of Dry Eye Disease (DED). Investigative Ophthalmology & Visual Science. 54(15). 4320–4320. 2 indexed citations
10.
11.
Schmidt, Michael M., Sharon A. Townson, Amy Andreucci, et al.. (2013). Crystal Structure of an HSA/FcRn Complex Reveals Recycling by Competitive Mimicry of HSA Ligands at a pH-Dependent Hydrophobic Interface. Structure. 21(11). 1966–1978. 92 indexed citations
12.
Hou, Jinzhao, Sharon A. Townson, Joseph Kovalchin, et al.. (2013). Design of a superior cytokine antagonist for topical ophthalmic use. Proceedings of the National Academy of Sciences. 110(10). 3913–3918. 47 indexed citations
13.
Kovalchin, Joseph, et al.. (2011). Macrophage-Specific Chemokines Induced via Innate Immunity by Amino Acid Copolymers and Their Role in EAE. PLoS ONE. 6(12). e26274–e26274. 8 indexed citations
14.
15.
Kovalchin, Joseph, Jeffrey Krieger, Tony Avril, et al.. (2010). Safety, Pharmacokinetic, and Pharmacodynamic Evaluations of PI-2301, a Potent Immunomodulator, in a First-in-Human, Single-Ascending-Dose Study in Healthy Volunteers. The Journal of Clinical Pharmacology. 51(5). 649–660. 8 indexed citations
16.
Kovalchin, Joseph, et al.. (2006). In vivo delivery of heat shock protein 70 accelerates wound healing by up‐regulating macrophage‐mediated phagocytosis. Wound Repair and Regeneration. 14(2). 129–137. 87 indexed citations
17.
Kovalchin, Joseph, et al.. (2005). In vivo treatment of mice with heat shock protein, gp96, improves survival of skin grafts with minor and major antigenic disparity. Transplant Immunology. 15(3). 179–185. 21 indexed citations
18.
19.
Kovalchin, Joseph, et al.. (2004). Glycoprotein 96 Can Chaperone Both MHC Class I- and Class II-Restricted Epitopes for In Vivo Presentation, but Selectively Primes CD8+ T Cell Effector Function. The Journal of Immunology. 172(10). 6087–6092. 111 indexed citations
20.
Kovalchin, Joseph, Ananth S. Murthy, Mark C. Horattas, Daniel P. Guyton, & Rajiv Y. Chandawarkar. (2001). Determinants of efficacy of immunotherapy with tumor-derived heat shock protein gp96.. PubMed. 1. 7–7. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Norikatsu Mizumoto Breakdown of academic impact, for papers by Sophie Bosset Breakdown of academic impact, for papers by Shoso Yamamoto Breakdown of academic impact, for papers by Meera S. Ramakrishnan Breakdown of academic impact, for papers by K Heije Breakdown of academic impact, for papers by Tiffany Frey Breakdown of academic impact, for papers by Hongmei Fu Breakdown of academic impact, for papers by S. S. Rabinowitz Breakdown of academic impact, for papers by Mara Hincenbergs Breakdown of academic impact, for papers by K Albrandt
Rankless by CCL
2026